Metraipolis › archive › dc_7ecdd239bcad
Validation of Preoperative Neoadjuvant Bevacizumab Therapy for Newly Diagnosed Glioblastoma via Comparative Analyses with Propensity Score Matching — Europe PMC PMID:41681960
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41681960
- DOI
- 10.3390/cancers18030488
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T09:20:55.359Z
- SHA-256 of the archived text
45191737446898543c9eee85046ffccf59689bd964be28983871a736e81f0e6f- Stable URL of this page
https://metraipolis.com/documento/dc_7ecdd239bcad
How to cite
Validation of Preoperative Neoadjuvant Bevacizumab Therapy for Newly Diagnosed Glioblastoma via Comparative Analyses with Propensity Score Matching — Europe PMC PMID:41681960 — Europe PMC (en), https://europepmc.org/article/MED/41681960 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7ecdd239bcad (Metraipolis archive dc_7ecdd239bcad, sha256 45191737446898543c9eee85046ffccf59689bd964be28983871a736e81f0e6f)
BibTeX
@misc{dc7ecdd239bcad,
title = {Validation of Preoperative Neoadjuvant Bevacizumab Therapy for Newly Diagnosed Glioblastoma via Comparative Analyses with Propensity Score Matching — Europe PMC PMID:41681960},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41681960},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7ecdd239bcad; sha256 45191737446898543c9eee85046ffccf59689bd964be28983871a736e81f0e6f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41681960. Agents can read the archived copy with the MCP tool read_document.